ArticleSmall science2025
Multifunctional Magnetic Ionic Liquid-Carbon Nanohorn Complexes for Targeted Cancer Theranostics.
Article in Small science, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Imidazole-based tetrachloridoferrate(iii) magnetic ionic liquids: structural insights, photosensitizing potential, and selective anti-glioblastoma activity.RSC advances · 2026Article
- Intrinsically Disordered Polypeptides-Based Stealth Materials Enable Enhanced Photothermal Cancer Therapy Using an In Situ Fiber-Based Penetrating Laser System.Small science · 2026Article
- A perspective on magnetic ionic liquids as multifunctional platforms for drug delivery and biomedical applications.Discover nano · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Establishing a rational and simplified design for nanoparticles that selectively target and eliminate cancer cells is a crucial aspect of cancer treatment. In this study, a new multifunctional nanocomplex is developed based on a photoexothermic carbon nanohorn comprising the magnetic and anticancer ionic liquids 1-butyl-3-methylimidazolium tetrachloroferrate and fluorescent indocyanine green, synthesized through a convenient sonication process. The synthesized nanocomplexes exhibit unique therapeutic, photothermal, magnetic, and fluorescent properties, enabling chemotherapeutic, light-, and magnetic-field-driven cancer theranostics. Furthermore, this nanocomplex demonstrates prolonged water-dispersing stability (7 days), high photothermal conversion efficiency (63%), and remarkable stability under biologically permeable near-infrared laser irradiation. Simple magnetic guidance significantly enhances the accumulation of nanocomplexes at tumor sites, facilitating targeted delivery. In vitro and in vivo studies have demonstrated potent anticancer efficacy, high selective cytotoxicity against cancer cells, and minimal impact on normal tissues. This study represents the first application of magnetic ionic liquids in cancer treatment and provides a valuable platform for advanced nanotheranostics.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.